Xianbin Yu

University of Chicago — United States

Medicine · Health Sciences

9h-index1.1kcitations26works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Brain Metastases and Treatment(11), Radiopharmaceutical Chemistry and Applications(10), RNA modifications and cancer(8), Cancer-related molecular mechanisms research(7), Cancer Immunotherapy and Biomarkers(2)

Publications26 total

Biomaterial-minimalistic photoactivated bioprinting of cell-dense tissues
Cell·2025· 1 cited
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
The Journal of Experimental Medicine·2025Open Access
N6-methyladenosine on L1PA governs the trans-silencing of LTRs and restrains totipotency in naive human embryonic stem cells
Cell stem cell·2025
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis
Nature·2024· 62 citedOpen Access
Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S2 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S7 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S5 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Data from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S10 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S1 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production
Journal of Clinical Investigation·2024· 18 citedOpen Access
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
Clinical Cancer Research·2024· 6 citedOpen Access
5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer
Gynecologic Oncology·2024· 8 citedOpen Access
Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance
Journal of Clinical Investigation·2023· 25 citedOpen Access
RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Nature Cell Biology·2023· 80 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Chuan He(21), Liangliang Wang(17), Xiaona Huang(17), Jiaai Wang(17), Hua Liang(17), Jason Bugno(16), András Piffkó(16), Kaiting Yang(15), Ralph R. Weichselbaum(15), Emile Naccasha(14), Stephen Y. Luo(13), Yuzhu Hou(13), Xuezhi Cao(12), Katherine Chen(12), Sherry Fu(12), Yang‐Xin Fu(12), Xiaoyang Dou(7), Boyang Gao(4), Sean P. Pitroda(4), Steven J. Chmura(4)